During the 2025 Cell and Gene Therapy World Congress, a critical session will explore the ethical challenges of using gene therapy for non-lethal conditions. Experts will debate the implications of applying gene editing technologies, such as CRISPR, for enhancing quality of life rather than addressing life-threatening diseases. Topics will include the risks of genetic enhancement, long-term societal effects, and the accessibility of these therapies. As part of the broader discussions at the Cell & Gene Therapy World Conference 2025, this session will provide insight into the ethical considerations guiding the future of gene therapy.